Seongnam, South Korea

Jae Young Lee

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Samyang Holdings Corporation. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae Young Lee. Retrieved from https://idiyas.com/inventor/jae-young-lee-q5fm4d66

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jae Young Lee in Oral Solid Dosage Forms

Introduction

Jae Young Lee is an accomplished inventor based in Seongnam, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral solid dosage forms. His innovative approach focuses on improving the disintegration and dissolution of these formulations.

Latest Patents

Jae Young Lee holds a patent for an oral solid dosage form composition that includes an active ingredient and a solubilizing carrier. This composition utilizes a foaming ingredient to enhance disintegration, dispersion, or dissolution. The preparation method for this composition is also disclosed in his patent, showcasing his expertise in pharmaceutical formulation.

Career Highlights

Lee is currently associated with Samyang Holdings Corporation, where he continues to work on advancing pharmaceutical technologies. His dedication to innovation has positioned him as a key figure in his field.

Collaborations

Some of his notable coworkers include Sang Yeob Park and Hye Jung Lim, who contribute to the collaborative efforts in research and development at Samyang Holdings Corporation.

Conclusion

Jae Young Lee's work in oral solid dosage forms exemplifies the importance of innovation in the pharmaceutical industry. His contributions are paving the way for more effective and efficient drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…